SB 265610

CAS No. 211096-49-0

SB 265610( SB265610 | SB-265610 )

Catalog No. M13354 CAS No. 211096-49-0

A potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 110 In Stock
10MG 177 In Stock
25MG 356 In Stock
50MG 530 In Stock
100MG 759 In Stock
500MG 1557 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    SB 265610
  • Note
    Research use only, not for human use.
  • Brief Description
    A potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM.
  • Description
    A potent, selective, reversible CXCR2 antagonist with with Kd of 3.48 nM; inhibits protein nitration induced by hyperoxia, reduces radical formation in hyperoxia-exposed newborn rat lung; also induces G1 arrest, ans shows anti-proliferative activity in in IL8-rich tumor microenvironments.
  • In Vitro
    ——
  • In Vivo
    Animal Model:MMTV-PyVmT/Tgfbr2MGKO and MMTV-PyVmT/Tgfbr2flox/flox tumors from donor mice Dosage:2 mg/kg/day Administration:Intraperitoneal injection; daily; for two weeks Result:Significantly inhibited the recruitment of Gr-1+CD11b+ cells to the mammary adenocarcinoma.
  • Synonyms
    SB265610 | SB-265610
  • Pathway
    GPCR/G Protein
  • Target
    Chemokine Receptor
  • Recptor
    Chemokine Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    211096-49-0
  • Formula Weight
    357.16
  • Molecular Formula
    C14H9BrN6O
  • Purity
    >98% (HPLC)
  • Solubility
    100 mM in DMSO
  • SMILES
    O=C(NC1=C2N=NNC2=C(C#N)C=C1)NC3=CC=CC=C3Br
  • Chemical Name
    N-(2-Bromophenyl)-N'-(7-cyano-1H-benzotriazol-4-yl)urea

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. de Kruijf P, et al. J Pharmacol Exp Ther. 2009 May;329(2):783-90. 2. Bradley ME, et al. Br J Pharmacol. 2009 Sep;158(1):328-38. 3. de Kruijf P, et al. Mol Pharmacol. 2011 Dec;80(6):1108-18. 4. Goda AE, et al. Anticancer Res. 2015 Jun;35(6):3235-43.
molnova catalog
related products
  • CX797

    A potent, specfic CXCR2 antagonist that inhibits IL8 down-regulation of forskolin-induced cAMP with IC50 of 7.79 uM.

  • TAK-220

    A potent, specific, orally bioavailable CCR5 antagonist that blocks the binding of MIP-1α to CCR5 with IC50 of 1.4 nM.

  • AZ 13381758

    A potent, small molecule CXCR2 inhibitor with IC50 of 26 nM and 30 nM for mCXCR2 and hCXCR2, respectively.